PharmaDrug advances its glaucoma research program with selection of lead DMT analog

PharmaDrug Inc CEO Daniel Cohen tells Proactive it has announced the selection of its final lead drug candidate from a short list of six DMT analogs as the...

Related Keywords

Daniel Cohen ,Pharmadrug Inc ,Terasaki Institute For Biomedical Research ,Terasaki Institute ,Biomedical Research ,